ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance.
Authors: Sánchez-Maldonado JM, Macauda A, Cabrera-Serrano AJ, Thomsen H, Güler M, Horst RT, van Guelpen B, Vodicka P, Landi S, Chattopadhyay S, Ünal P, Ruiz-Durán L, Casabonne D, Goldschmidt H, Serin I, Carretero-Fernández M, Cabezudo E, Reyes-Zurita F, Norman AD, García-Sanz R, Capurso G, Hoffmann P, Pettersson-Kymmer U, Jiménez-Romera F, Rajkumar SV, Weinhold N, Vodickova L, Langer C, Stein A, Karismaz A, Moreno V, Nöthen MM, Jöckel KH, Tavano F, Martínez-López J, Kumar SK, Gutiérrez-Bautista JF, Basso D, Späth F, Benavente Y, Hildebrandt MAT, Schmidt B, Sevcikova T, Reis RMV, Li Y, López-Nevot MÁ, Netea MG, Campa D, Clay-Gilmour A, Slager SL, Hemminki K, Vachon CM, Försti A, Canzian F, Sainz J
03/2026 - International journal of cancer
